Based on the Avantor Inc stock forecast from 8 analysts, the average analyst target price for Avantor Inc is USD 27.80 over the next 12 months. Avantor Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Avantor Inc is Neutral, which is based on 5 positive signals and 5 negative signals. At the last closing, Avantor Inc’s stock price was USD 20.78. Avantor Inc’s stock price has changed by +0.19% over the past week, -13.05% over the past month and +3.43% over the last year.
No recent analyst target price found for Avantor Inc
No recent average analyst rating found for Avantor Inc
Company Overview Avantor Inc
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania. Address: Radnor Corporate Center, Radnor, PA, United States, 19087 Read Less
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company of...Read More
Frequently Asked Questions About Avantor Inc (AVTR) Stock
Based on ratings from 8 analysts Avantor Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 9 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on AVTR's stock to indicate if its a good dividend stock.
Based on targets from 8 analysts, the average taret price for AVTR is USD 27.80 over the next 12 months. The maximum analyst target price is USD 34 while the minimum anlayst target price is USD 23.
AVTR stock's Price/Earning ratio is 46.18.
Our analysis grades AVTR stock's Price / Earning ratio at F. This means that AVTR stock's Price/Earning ratio is above 64% of the stocks in the Medical Instruments & Supplies sector in the NYE exchange.
Based on this AVTR may be a overvalued for its sector.
The last closing price of AVTR's stock was USD 20.78.
The most recent market capitalization for AVTR is USD 14.14B.
Based on targets from 8 analysts, the average taret price for AVTR is projected at USD 27.80 over the next 12 months.
This means that AVTR's stock price may go up by +33.78% over the next 12 months.
We can't find any ETFs which contains Avantor Inc's stock.
As per our most recent records Avantor Inc has 14,500 Employees.
Avantor Inc's registered address is Radnor Corporate Center, Radnor, PA, United States, 19087.
You can get more information about it from Avantor Inc's website at https://www.avantorsciences.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Avantor Inc (AVTR) Stock
Based on ratings from 8 analysts Avantor Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 9 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on AVTR's stock to indicate if its a good dividend stock.
Based on targets from 8 analysts, the average taret price for AVTR is USD 27.80 over the next 12 months. The maximum analyst target price is USD 34 while the minimum anlayst target price is USD 23.
AVTR stock's Price/Earning ratio is 46.18.
Our analysis grades AVTR stock's Price / Earning ratio at F. This means that AVTR stock's Price/Earning ratio is above 64% of the stocks in the Medical Instruments & Supplies sector in the NYE exchange.
Based on this AVTR may be a overvalued for its sector.
The last closing price of AVTR's stock was USD 20.78.
The most recent market capitalization for AVTR is USD 14.14B.
Based on targets from 8 analysts, the average taret price for AVTR is projected at USD 27.80 over the next 12 months.
This means that AVTR's stock price may go up by +33.78% over the next 12 months.
We can't find any ETFs which contains Avantor Inc's stock.
As per our most recent records Avantor Inc has 14,500 Employees.
Avantor Inc's registered address is Radnor Corporate Center, Radnor, PA, United States, 19087.
You can get more information about it from Avantor Inc's website at https://www.avantorsciences.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for AVTR !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
